Clinical Trial Update: Intracoronary Injection of Epo After Myocardial Infarct "Intra-CO-EpoMI" [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating intracoronary erythropoietin after acute myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Acute Myocardial Infarct | Phase 3 | Status: COMPLETED